# FDA Inspection 1148264 - Rishi Kakar, M.D. - August 09, 2021

Source: https://www.keypedia.com/records/fda_inspections/rishi-kakar-md/cb941bec-9e6b-4f0f-91f4-6a714d436386
Source feed: FDA_Inspections

> FDA Inspection 1148264 for Rishi Kakar, M.D. on August 09, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1148264
- Company Name: Rishi Kakar, M.D.
- Inspection Date: 2021-08-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1227979 - 2024-01-22](https://www.keypedia.com/records/fda_inspections/rishi-kakar-md/8b8d7438-4ee8-422c-bdba-5b71a9343986)
- [FDA Inspection 1102117 - 2019-08-29](https://www.keypedia.com/records/fda_inspections/rishi-kakar-md/3d3041bd-b525-41ac-8e68-7e5d470134ee)
- [FDA Inspection 1078107 - 2018-12-11](https://www.keypedia.com/records/fda_inspections/rishi-kakar-md/c19d04ca-50ba-45fd-a574-5cae6dbaf94e)

Company: https://www.keypedia.com/companies/rishi-kakar-md/d040b86d-d6aa-43a7-941e-d74bdb757a3a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c